THRX up +1.57% percent Today $THRX High is at 13.61 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 1:58 PM

THRX up +1.57% percent Today $THRX High is at 13.61 and the Low 13.17 with current volume of 79,966.

Recent News posted below.

Theravance THRX other info.
http://investorshangout.com/Theravance-THRX-55637/

THRX Theravance Recent Headline News

Patient recruitment complete in "real-world" COPD study
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 7:32AM CST

THRX: 13.58 (+0.23), GSK: 46.41 (+0.13)

Theravance Earnings Review: 18 Days after Announcement Shares Down 18.4% (THRX)
Comtex SmarTrend(R) - Mon Nov 17, 4:04PM CST
When Theravance (NASDAQ:THRX) reported earnings two weeks ago on October 30th, 2014, analysts, on average, expected the company to report a loss of $0.13 on sales of $6.9 million. Theravance actually reported a loss of $0.19 per share on sales of $999.0 thousand, missing EPS estimates by $0.06 and missing revenue estimates by $5.9 million. Shares of Theravance have slipped from $16.21 to $13.23, representing a loss of 18.4%, since the company reported earnings 18 days ago.
THRX: 13.58 (+0.23)

Tracking Seth Klarman's Baupost Group Holdings - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 9:14AM CST

OCN: 21.24 (+0.19), KOS: 9.44 (+0.05), KIN: 8.96 (+0.05), VSAT: 65.64 (+0.10), RFMD: 13.69 (-0.06), EBAY: 55.03 (-0.35), TQNT: 22.85 (-0.08), IDIX: 24.50 (+0.05), SEMI: 16.65 (-0.01), VRTV: 50.69 (+2.30), THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), IMOS: 20.70 (-0.91), ELOS: 9.90 (-0.03), MU: 32.75 (-0.12), AR: 52.98 (+0.83), NCQ: 0.69 (unch), PBF: 28.38 (+0.72), LNG: 72.71 (+0.95), ATRA: 26.63 (+0.28), KERX: 15.26 (-0.28), NG: 2.95 (-0.08), AOI: 1.89 (-0.01), FWP: 21.39 (+0.25), BYD: 11.70 (-0.04), ALDW: 17.67 (+0.11), SUNE: 21.39 (-0.09), MRK: 59.55 (-0.34), AVEO: 0.99 (+0.04), AIG: 54.03 (+0.14)

Update: Theravance Reveals Interesting Bits Of Information At CS Conference
Early Retiree - at Seeking Alpha - Fri Nov 14, 10:53AM CST

THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), GSK: 46.41 (+0.13)

Shares of THRX Down 51.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 14, 9:38AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 51.85% as of today's recent price of $13.16.
THRX: 13.58 (+0.23)

Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 2:38PM CST

THRX: 13.58 (+0.23)

When Is It Time To Accumulate Theravance?
Chris Lau - at Seeking Alpha - Tue Nov 11, 10:50AM CST

MRK: 59.55 (-0.34), AZN: 75.42 (+1.44), THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12)

Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:44AM CST

MRK: 59.55 (-0.34), AZN: 75.42 (+1.44), AMGN: 162.74 (+0.50), TEVA: 57.22 (-0.01), THRX: 13.58 (+0.23), GSK: 46.40 (+0.12), SNY: 48.34 (-0.02), REGN: 416.75 (+3.53), NVS: 95.75 (+0.17)

Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:20AM CST
Theravance Biopharma reported a third-quarter 2014 loss of $1.72 per share.
AMAG: 35.69 (+0.35), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23)

Shares of THRX Down 47.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:10AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 47.93% as of today's recent price of $14.23.
THRX: 13.58 (+0.23)

5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More
at The Street - Thu Nov 06, 11:45AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
SCCO: 29.83 (-0.49), WRLD: 78.19 (+1.12), NS: 59.40 (-0.40), THRX: 13.58 (+0.23), HUN: 26.02 (-0.31)

Theravance to Present at Two Upcoming Investor Conferences in November
Marketwired - Wed Nov 05, 3:08PM CST
Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November.
THRXV: 28.00 (+7.07), THRX: 13.58 (+0.23)

Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 35.52 (+0.22), TJX: 61.84 (+0.20), NKE: 97.00 (+0.53), TGT: 72.12 (+4.61), WMT: 85.13 (+1.34), HBI: 111.75 (+1.32), THRX: 13.58 (+0.23), KORS: 72.87 (-0.06), GPS: 39.40 (+0.05), RL: 178.76 (+2.20), LULU: 45.50 (+0.70)

InsiderInsights.com Daily Round Up 11/4/14: UFI, SABA, CCI
InsiderInsights - at Seeking Alpha - Wed Nov 05, 8:31AM CST

CCI: 80.67 (+0.15), CBG: 32.94 (-0.20), HGG: 6.11 (+0.07), LLY: 67.11 (-0.67), BA: 132.01 (+1.35), MAR: 76.73 (-0.21), QNST: 4.31 (-0.09), OZRK: 35.95 (+0.08), APO: 23.04 (-0.30), STAA: 8.69 (-0.01), AMBR: 11.19 (-0.05), FSAM: 14.53 (-0.23), WRLD: 78.19 (+1.12), CPLA: 69.38 (+0.59), THRX: 13.58 (+0.23), MSFT: 48.16 (-0.58), UFI: 27.29 (+0.17), AN: 58.23 (+0.50), CRM: 61.36 (-1.11)

FDA accepts BI's Spiriva NDA for asthma
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:06PM CST

AZN: 75.42 (+1.44), TEVA: 57.22 (-0.01), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23), SNY: 48.34 (-0.02), REGN: 416.75 (+3.53), NVS: 95.75 (+0.17)

7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST

KND: 20.53 (+0.53), VIVO: 16.04 (-0.10), PETS: 13.35 (-0.15), PFE: 30.37 (-0.22), GSK: 46.40 (+0.12), MR: 30.93 (+0.17), SEM: 13.78 (-0.06), PDLI: 7.94 (-0.03), SNN: 34.14 (+0.36), AZN: 75.42 (+1.44), MRK: 59.55 (-0.34), STJ: 63.84 (-1.11), TRIB: 17.10 (-0.15), ABBV: 65.59 (-0.46), THRX: 13.58 (+0.23), SNY: 48.34 (-0.02)

Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:10AM CST
Theravance reported third-quarter 2014 loss of 19 cents per share.
AMAG: 35.69 (+0.35), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23)

Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:00AM CST
Bayer's (BAYRY) earnings during the third quarter of 2014 came in at roughly $1.79 per share.
MRK: 59.55 (-0.34), AMAG: 35.69 (+0.35), THRX: 13.58 (+0.23)

Update: GSK Starts Promoting Theravance Drugs More Actively
Early Retiree - at Seeking Alpha - Sat Nov 01, 7:42AM CDT

THRX: 13.58 (+0.23), GSK: 46.40 (+0.12)

More on Theravance Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:03PM CDT

THRX: 13.58 (+0.23)

Innoviva, Inc. (INVA) Stock Research Links

INVA Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Curaleaf Eyes Growth: Conference Signals Opportunities

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Hydrogen Mobility Gains Steam: Industry & Policy Unite

The winds are changing, and this time, it's hydrogen that's blowing into town. Europe may just be on the brink of a major trucking overhaul, driven by a concoction of industry giants and supportive policies. The stage is set for hydrogen trucks to roll out by 2030, aiming to gut traditional fuel options and stack the odds in favor of zero-emission transport. Can you smell...

Russo-Rodriguez: A New Era in Florida Politics?

A Political Shake-Up in Florida On a seemingly regular day in New Smyrna Beach, Frank Russo, the independent candidate for governor, decided to toss a wrench into Florida's political machine. By naming Rachel Rodriguez as his running mate, he's forging a new path that challenges entrenched party norms. This Russo-Rodriguez ticket is stirring the political pot,...

PROCEPT Faces Legal Storm Over Sales Practices Missteps

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Connected Retail Security: Rising Risks and Fragmented Roles

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Cango's EcoHash Marks AI Move with Key Milestones

AI Expansion at EcoHash: A Strategic Stride Some days you wake up, read a company pushing its legacy into something new, and you just gotta wonder if they’ve hit paydirt or just blowing smoke. For Cango Inc. and its subsidiary EcoHash, this latest update is shaping up interesting. They're no small potatoes in mining Bitcoins, but they're now trying their hand at AI...